Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Peter Wolfe

Peter Wolfe is recorded as CFO at ZyVersa Therapeutics, Inc. (ZVSA). ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Peter Wolfe was appointed Chief Financial Officer and Secretary. ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Peter Wolfe was appointed Chief Financial Officer and Secretary, effective December 12, 2022. The proxy statement of ZyVersa Therapeutics, Inc. reports total compensation of $573,359 for Peter Wolfe in fiscal 2023, including a base salary of $395,000. Disclosed compensation is on record for 2 fiscal years.

“Peter Wolfe was appointed Chief Financial Officer and Secretary”
ZyVersa Therapeutics, Inc. Form 8-K, filed December 13, 2022 · Read the filing
“Peter Wolfe was appointed Chief Financial Officer and Secretary”
ZyVersa Therapeutics, Inc. Form 8-K, filed December 13, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ZyVersa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 ZyVersa Therapeutics, Inc. (ZVSA) $395,000 $573,359
2022 ZyVersa Therapeutics, Inc. (ZVSA) $275,000 $557,622

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.